JP2020535130A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020535130A5 JP2020535130A5 JP2020516508A JP2020516508A JP2020535130A5 JP 2020535130 A5 JP2020535130 A5 JP 2020535130A5 JP 2020516508 A JP2020516508 A JP 2020516508A JP 2020516508 A JP2020516508 A JP 2020516508A JP 2020535130 A5 JP2020535130 A5 JP 2020535130A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- payload
- superpartners
- neurotrophic factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 22
- 108010025020 Nerve Growth Factor Proteins 0.000 claims 6
- 102000007072 Nerve Growth Factors Human genes 0.000 claims 6
- 239000003900 neurotrophic factor Substances 0.000 claims 6
- 235000010443 alginic acid Nutrition 0.000 claims 4
- 239000000783 alginic acid Substances 0.000 claims 4
- 229920000615 alginic acid Polymers 0.000 claims 4
- 229960001126 alginic acid Drugs 0.000 claims 4
- 150000004781 alginic acids Chemical class 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 3
- 239000002105 nanoparticle Substances 0.000 claims 3
- 229920001282 polysaccharide Polymers 0.000 claims 3
- 239000005017 polysaccharide Substances 0.000 claims 3
- 150000004804 polysaccharides Chemical class 0.000 claims 3
- 239000011148 porous material Substances 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000007787 electrohydrodynamic spraying Methods 0.000 claims 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical class CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims 1
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 claims 1
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 claims 1
- 206010011878 Deafness Diseases 0.000 claims 1
- 208000003098 Ganglion Cysts Diseases 0.000 claims 1
- 229920002527 Glycogen Polymers 0.000 claims 1
- 102000004230 Neurotrophin 3 Human genes 0.000 claims 1
- 108090000742 Neurotrophin 3 Proteins 0.000 claims 1
- 208000005400 Synovial Cyst Diseases 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 230000002902 bimodal effect Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 231100000895 deafness Toxicity 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 238000010304 firing Methods 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 229940096919 glycogen Drugs 0.000 claims 1
- 208000016354 hearing loss disease Diseases 0.000 claims 1
- 239000000017 hydrogel Substances 0.000 claims 1
- 230000001788 irregular Effects 0.000 claims 1
- 210000002569 neuron Anatomy 0.000 claims 1
- 239000004090 neuroprotective agent Substances 0.000 claims 1
- 229940032018 neurotrophin 3 Drugs 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
- 230000004083 survival effect Effects 0.000 claims 1
- 238000013268 sustained release Methods 0.000 claims 1
- 239000012730 sustained-release form Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2017903828A AU2017903828A0 (en) | 2017-09-20 | Improved supraparticles | |
| AU2017903829A AU2017903829A0 (en) | 2017-09-20 | Method of treatment | |
| AU2017903829 | 2017-09-20 | ||
| AU2017903828 | 2017-09-20 | ||
| AU2018902513A AU2018902513A0 (en) | 2018-07-11 | Improved supraparticles | |
| AU2018902513 | 2018-07-11 | ||
| PCT/AU2018/051029 WO2019056062A1 (en) | 2017-09-20 | 2018-09-20 | SUPERPARTICLES IMPROVED |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020535130A JP2020535130A (ja) | 2020-12-03 |
| JP2020535130A5 true JP2020535130A5 (https=) | 2021-11-11 |
| JP7404231B2 JP7404231B2 (ja) | 2023-12-25 |
Family
ID=65810122
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020516508A Active JP7404231B2 (ja) | 2017-09-20 | 2018-09-20 | 改良された超粒子 |
| JP2020516514A Pending JP2020535131A (ja) | 2017-09-20 | 2018-09-20 | 処置の方法 |
| JP2023131227A Pending JP2023154035A (ja) | 2017-09-20 | 2023-08-10 | 処置の方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020516514A Pending JP2020535131A (ja) | 2017-09-20 | 2018-09-20 | 処置の方法 |
| JP2023131227A Pending JP2023154035A (ja) | 2017-09-20 | 2023-08-10 | 処置の方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (5) | US20200253865A1 (https=) |
| EP (2) | EP3684342B1 (https=) |
| JP (3) | JP7404231B2 (https=) |
| CN (2) | CN111225663A (https=) |
| AU (2) | AU2018337076B2 (https=) |
| ES (2) | ES2962580T3 (https=) |
| WO (2) | WO2019056061A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018337076B2 (en) | 2017-09-20 | 2024-09-26 | The Bionics Institute Of Australia | Method of treatment |
| BR112020020930A2 (pt) * | 2018-04-11 | 2021-03-02 | Ohio State Innovation Foundation | composição de liberação de fármaco, método para tratar um distúrbio oftalmológico e kit |
| EP3941442A4 (en) * | 2019-03-19 | 2022-12-21 | The Bionics Institute of Australia | SUPRAPARTICLE FORMULATIONS |
| CN110063968B (zh) * | 2019-04-18 | 2021-09-03 | 朗姿赛尔生物科技（广州）有限公司 | 一种特异性干细胞修复病变胰岛的方法 |
| US20230047254A1 (en) * | 2019-12-29 | 2023-02-16 | Gloriana Therapeutics | Mammalian Cells Secreting GDNF and Their Therapeutic Use |
| WO2022269540A1 (en) * | 2021-06-24 | 2022-12-29 | Cochlear Limited | Methods and pharmaceutical formulations for modulating the properties of the blood labyrinth barrier |
| GB202213060D0 (en) * | 2022-09-07 | 2022-10-19 | Rinri Therapeutics Ltd | Surgical method for treatment of auditory disease or condition |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4468498A (en) | 1980-06-12 | 1984-08-28 | Rohm And Haas Company | Sequential heteropolymer dispersion and a particulate materal obtainable therefrom, useful in coating compositions as a thickening and/or opacifying agent |
| US5521253A (en) | 1990-10-12 | 1996-05-28 | The Dow Chemical Company | Hollow polymer latex particles |
| US5157084A (en) | 1990-10-12 | 1992-10-20 | The Dow Chemical Company | Process of making hollow polymer latex particles |
| SE9903958D0 (sv) | 1999-11-02 | 1999-11-02 | Boerje Sellergren | Porous materials for selective binding or transport of molecular guests |
| WO2006037160A1 (en) | 2004-10-05 | 2006-04-13 | The University Of Melbourne | Porous polyelectrolyte materials |
| WO2009079688A1 (en) | 2007-12-21 | 2009-07-02 | The University Of Melbourne | Porous silica shell-mediated assembly of macromolecular capsules |
| CN102380102A (zh) * | 2011-11-02 | 2012-03-21 | 东华大学 | 一种环境响应性介孔硅纳米粒子的制备方法 |
| ES2657137T5 (en) * | 2012-03-28 | 2025-02-12 | Borealis Ag | Multimodal polymer |
| CN104582782B (zh) * | 2012-08-20 | 2018-11-27 | 奥雷制药有限公司 | 用于制备药物递送制剂的方法 |
| WO2015051364A1 (en) * | 2013-10-05 | 2015-04-09 | Omnova Solutions Inc | Supraparticles including hollow polymeric particles |
| US9534213B2 (en) | 2014-03-04 | 2017-01-03 | The Regents Of The University Of Michigan | Spontaneously formed terminal supraparticles having nanoparticles for protein stabilization |
| CN104003404B (zh) * | 2014-05-19 | 2016-03-16 | 国家纳米科学中心 | 一种多孔二氧化硅纳米粒子的制备方法及其用途 |
| AU2018337076B2 (en) | 2017-09-20 | 2024-09-26 | The Bionics Institute Of Australia | Method of treatment |
-
2018
- 2018-09-20 AU AU2018337076A patent/AU2018337076B2/en active Active
- 2018-09-20 JP JP2020516508A patent/JP7404231B2/ja active Active
- 2018-09-20 EP EP18857932.0A patent/EP3684342B1/en active Active
- 2018-09-20 WO PCT/AU2018/051028 patent/WO2019056061A1/en not_active Ceased
- 2018-09-20 EP EP18858164.9A patent/EP3684343B1/en active Active
- 2018-09-20 AU AU2018337668A patent/AU2018337668B2/en active Active
- 2018-09-20 US US16/648,858 patent/US20200253865A1/en not_active Abandoned
- 2018-09-20 JP JP2020516514A patent/JP2020535131A/ja active Pending
- 2018-09-20 CN CN201880068028.5A patent/CN111225663A/zh active Pending
- 2018-09-20 CN CN201880069810.9A patent/CN111278428A/zh active Pending
- 2018-09-20 ES ES18858164T patent/ES2962580T3/es active Active
- 2018-09-20 ES ES18857932T patent/ES2985193T3/es active Active
- 2018-09-20 WO PCT/AU2018/051029 patent/WO2019056062A1/en not_active Ceased
-
2019
- 2019-07-01 US US16/459,263 patent/US11369661B2/en active Active
-
2022
- 2022-05-25 US US17/824,654 patent/US12048733B2/en active Active
- 2022-12-21 US US18/086,412 patent/US20230135903A1/en not_active Abandoned
-
2023
- 2023-08-10 JP JP2023131227A patent/JP2023154035A/ja active Pending
-
2025
- 2025-01-17 US US19/028,757 patent/US20250205308A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020535130A5 (https=) | ||
| Hakim et al. | Biocompatible and biomaterials application in drug delivery system in oral cavity | |
| CN1993113B (zh) | 包含磷酸钙纳米颗粒核心，生物分子和胆汁酸的颗粒，其生产方法，其治疗用途 | |
| Chan et al. | Effects of photochemical crosslinking on the microstructure of collagen and a feasibility study on controlled protein release | |
| US9561190B2 (en) | Nonwoven membrane as a drug delivery system | |
| EP2696855B1 (en) | Coated mesoporous nanoparticles | |
| JP6846351B2 (ja) | 粘膜表面における活性薬剤の増強された輸送のための低張ヒドロゲル製剤 | |
| JP2023513740A (ja) | エレクトロスピニングされるポリマーをベースとした天然組成物、およびその作製方法 | |
| JP2013503654A (ja) | キトサン組織被覆材 | |
| JP7404231B2 (ja) | 改良された超粒子 | |
| CN105326535B (zh) | 一种医用吻合钉及其制备方法 | |
| JP2020520956A5 (https=) | ||
| Yuan et al. | One-pot preparation of polymer microspheres with different porous structures to sequentially release bio-molecules for cutaneous regeneration | |
| Ding et al. | Facile fabrication of hollow mesoporous bioactive glass spheres: From structural behaviour to in vitro biology evaluation | |
| CN107982239A (zh) | 疏水性药物晶体为模板的蛋白基非球形微囊及制备方法 | |
| Silva et al. | Composites based on chitosan and inorganic materials for biomedical applications | |
| KR102034982B1 (ko) | Pdrn이 캡슐화된 키토산 나노 입자가 포함된 점안제 및 이의 제조 방법 | |
| JP2018500898A (ja) | 非イオン性極性アミノ酸を含む自己組織化ペプチド | |
| WO2015126234A1 (es) | Método para la obtención de microesferas de liberación controlada de activos sensibles preparadas por ensamblaje de microesferas porosas y nanopartículas | |
| Khalid et al. | Biopolymeric-inorganic composites for drug delivery applications | |
| CN114376964B (zh) | 一种葛根素纳米粒成膜水凝胶制剂及其制备方法 | |
| Li | Alginate-based inhalable particles for controlled pulmonary drug delivery | |
| CN109568645B (zh) | 一种复合生长因子促修复凝胶及其制备方法与应用 | |
| KR101840256B1 (ko) | 레바미피드를 함유하는 새로운 안구건조증 치료용 점안 조성물 및 이의 가용화 및 안정화 방법 | |
| JP2022525945A5 (https=) |